Pediatrix Medical Group 8-K Filing: Key Updates for Investors - January 12, 2025

$MD
Form 8-K
Filed on: 2025-01-14
Source
Pediatrix Medical Group 8-K Filing: Key Updates for Investors - January 12, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted and summarized:

  1. Entity Information:
  • Company Name: Pediatrix Medical Group, Inc.
  • CIK (Central Index Key): 0000893949
  • State of Incorporation: Florida (FL)
  • SEC File Number: 001-12111
  • Employer Identification Number (EIN): 26-3667538
  • Address: 1301 Concord Terrace, Sunrise, FL 33323
  • Contact Number: 954-384-0175
  1. Filing Type:
  • Form Type: 8-K (This form is used to report major events that shareholders should know about.)
  1. Date of Filing:
  • Filing Date: January 12, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.01 per share
  • Exchange Listing: NYSE (New York Stock Exchange)
  1. Filing Context:
  • This filing reflects a specific duration context where the start and end date is January 12, 2025, indicating it might pertain to an event or condition occurring on the same day.

Insights:

  • The 8-K filing indicates that an important event or information regarding Pediatrix Medical Group occurred on January 12, 2025, which warrants disclosure to shareholders.
  • The details regarding the common stock suggest that the company is publicly traded and may be subject to regulatory scrutiny concerning its reporting and corporate governance.
  • The lack of additional context or event descriptions means that further details would be needed to assess the nature of the event reported in the 8-K filing.

This information is crucial for investors and analysts monitoring Pediatrix Medical Group as it provides insights into significant corporate actions and compliance with SEC regulations.